Del Valle Rubido, Marta
Hollander, Eric
McCracken, James T.
Shic, Frederick
Noeldeke, Jana
Boak, Lauren
Khwaja, Omar
Sadikhov, Shamil
Fontoura, Paulo
Umbricht, Daniel
Funding for this research was provided by:
F. Hoffmann-La Roche
Article History
First Online: 11 April 2020
Change Date: 4 May 2020
Change Type: Correction
Change Details: The original version of this article unfortunately contained a mistake in CI values in Table 2.
Compliance with Ethical Standards
:
: EH has provided consultation to Roche and received research grants from Roche, Curemark, Coronado Biosciences, Forest, Simons Foundation, Foundation for Prader Willi Research, and the Orphan Products Division of the Food and Drug Administration, and has intellectual property relating to oxytocin and autism. FS has provided consultation to Roche and Janssen Pharmaceutical and has received research grants from Roche, NIH, and the Simons Foundation. JTM has served as a consultant for Roche and Dart Neuroscience, has received research grants from Roche, and has received study drug from Shire and AstraZeneca. FS has received research funding from Roche and Janssen Pharmaceuticals. MVR, DU, JN, LB, OK, SS and PF are full-time employees of F. Hoffmann-La Roche.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.